Rare diseases
Investigational molecules
Locations
Back to Czechia21 clinical trials in Klatovy, Czechia across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)Long‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis
CzechiaA Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis
CzechiaA study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy
CzechiaA study testing duvakitug for patients with moderately to severely active ulcerative colitis
CzechiaA study of the safety and efficacy of AC01 in patients with heart failure with reduced ejection fraction
CzechiaEffect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)
CzechiaStudy of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
CzechiaA study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)
CzechiaStudy of AZD0780 in patients with high cholesterol and heart disease or risk of heart disease to lower bad cholesterol levels
CzechiaStudy on the Effects of Amlitelimab for Adults with Non-Responsive Celiac Disease
CzechiaStudy on the Long-Term Effects of TEV-48574 (Duvakitug) for Adults with Moderate to Severe Ulcerative Colitis or Crohn's Disease
CzechiaStudy of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Comprehensive studies focusing on ulcerative colitis and Crohn's disease treatments, evaluating novel therapeutic approaches for patients with moderate to severe conditions.
Multiple parallel investigations examining both short-term efficacy and long-term maintenance therapy outcomes.
Investigation comparing different sources of chondroitin sulfate in treating knee osteoarthritis, examining efficacy and safety profiles of marine versus bovine origins.
Focus on improving mobility and reducing pain in patients with moderate to severe symptoms.
Advanced research into celiac disease treatments, including studies of novel antibody therapies and their effectiveness in combination with dietary interventions.
Evaluating innovative approaches for patients who don't respond to traditional treatments.
Clinical evaluation of treatments for peripheral edema, comparing the effectiveness of different medications in patients on long-term therapy.
Focus on improving patient comfort and treatment outcomes through medication optimization.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
